Home Applications 205234 Application 205234
Type ANDA
Sponsor ALEMBIC PHARMS LTD Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 TELMISARTAN AND AMLODIPINE AMLODIPINE BESYLATE; TELMISARTAN TABLET;ORAL EQ 5MG BASE;40MG No No 002 TELMISARTAN AND AMLODIPINE AMLODIPINE BESYLATE; TELMISARTAN TABLET;ORAL EQ 10MG BASE;40MG No No 003 TELMISARTAN AND AMLODIPINE AMLODIPINE BESYLATE; TELMISARTAN TABLET;ORAL EQ 5MG BASE;80MG No No 004 TELMISARTAN AND AMLODIPINE AMLODIPINE BESYLATE; TELMISARTAN TABLET;ORAL EQ 10MG BASE;80MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A205234-001 TELMISARTAN AND AMLODIPINE AMLODIPINE BESYLATE; TELMISARTAN EQ 5MG BASE;40MG TABLET / ORAL 2016-11-17 A205234-002 TELMISARTAN AND AMLODIPINE AMLODIPINE BESYLATE; TELMISARTAN EQ 10MG BASE;40MG TABLET / ORAL 2016-11-17 A205234-003 TELMISARTAN AND AMLODIPINE AMLODIPINE BESYLATE; TELMISARTAN EQ 5MG BASE;80MG TABLET / ORAL 2016-11-17 A205234-004 TELMISARTAN AND AMLODIPINE AMLODIPINE BESYLATE; TELMISARTAN EQ 10MG BASE;80MG TABLET / ORAL 2016-11-17
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 180 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A205234-001 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;40MG TABLET / ORAL 2016-11-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A205234-002 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;40MG TABLET / ORAL 2016-11-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A205234-003 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;80MG TABLET / ORAL 2016-11-17 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A205234-004 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;80MG TABLET / ORAL 2016-11-17 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A205234-001 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;40MG TABLET / ORAL 2016-11-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 A205234-002 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;40MG TABLET / ORAL 2016-11-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 A205234-003 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;80MG TABLET / ORAL 2016-11-17 c2088c7a36db…2026-10-15 13:18:30 2026-09 A205234-004 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;80MG TABLET / ORAL 2016-11-17 c2088c7a36db…2026-09-14 22:38:34 2026-08 A205234-001 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;40MG TABLET / ORAL 2016-11-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 A205234-002 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;40MG TABLET / ORAL 2016-11-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 A205234-003 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;80MG TABLET / ORAL 2016-11-17 84e616aacf4f…2026-09-14 22:38:34 2026-08 A205234-004 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;80MG TABLET / ORAL 2016-11-17 84e616aacf4f…2026-08-18 06:07:40 2026-07 A205234-001 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;40MG TABLET / ORAL 2016-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A205234-002 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;40MG TABLET / ORAL 2016-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A205234-003 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;80MG TABLET / ORAL 2016-11-17 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A205234-004 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;80MG TABLET / ORAL 2016-11-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A205234-001 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;40MG TABLET / ORAL 2016-11-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A205234-002 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;40MG TABLET / ORAL 2016-11-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A205234-003 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;80MG TABLET / ORAL 2016-11-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A205234-004 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;80MG TABLET / ORAL 2016-11-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A205234-001 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;40MG TABLET / ORAL 2016-11-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A205234-002 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;40MG TABLET / ORAL 2016-11-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A205234-003 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;80MG TABLET / ORAL 2016-11-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A205234-004 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;80MG TABLET / ORAL 2016-11-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A205234-001 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;40MG TABLET / ORAL 2016-11-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A205234-002 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;40MG TABLET / ORAL 2016-11-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A205234-003 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;80MG TABLET / ORAL 2016-11-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A205234-004 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;80MG TABLET / ORAL 2016-11-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A205234-001 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;40MG TABLET / ORAL 2016-11-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A205234-002 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;40MG TABLET / ORAL 2016-11-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A205234-003 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;80MG TABLET / ORAL 2016-11-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A205234-004 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;80MG TABLET / ORAL 2016-11-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A205234-001 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;40MG TABLET / ORAL 2016-11-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A205234-002 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;40MG TABLET / ORAL 2016-11-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A205234-003 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;80MG TABLET / ORAL 2016-11-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A205234-004 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;80MG TABLET / ORAL 2016-11-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A205234-001 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;40MG TABLET / ORAL 2016-11-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A205234-002 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;40MG TABLET / ORAL 2016-11-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A205234-003 TELMISARTAN AND AMLODIPINE EQ 5MG BASE;80MG TABLET / ORAL 2016-11-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A205234-004 TELMISARTAN AND AMLODIPINE EQ 10MG BASE;80MG TABLET / ORAL 2016-11-17 03ed91905a0d…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 8 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 46708-184 Telmisartan and Amlodipine Telmisartan and Amlodipine Alembic Pharmaceuticals Limited ANDA Current 46708-184 Telmisartan and Amlodipine Telmisartan and Amlodipine Alembic Pharmaceuticals Limited ANDA Current 46708-185 Telmisartan and Amlodipine Telmisartan and Amlodipine Alembic Pharmaceuticals Limited ANDA Current 46708-185 Telmisartan and Amlodipine Telmisartan and Amlodipine Alembic Pharmaceuticals Limited ANDA Current 46708-186 Telmisartan and Amlodipine Telmisartan and Amlodipine Alembic Pharmaceuticals Limited ANDA Current 46708-186 Telmisartan and Amlodipine Telmisartan and Amlodipine Alembic Pharmaceuticals Limited ANDA Current 46708-187 Telmisartan and Amlodipine Telmisartan and Amlodipine Alembic Pharmaceuticals Limited ANDA Current 46708-187 Telmisartan and Amlodipine Telmisartan and Amlodipine Alembic Pharmaceuticals Limited ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 46029 ORIG 2016-12-06